Herein, we assessed 121 blastoid-HGBL cases in comparison with 47 B-ALL cases enriched for CD34-negative neoplasm to validate the six-point scoring system in all tissue types and to compare the two scoring systems. This evidence concerns the gene CD34 and precursor B-cell acute lymphoblastic leukemia.